A detailed history of Encompass More Asset Management transactions in Abbott Laboratories stock. As of the latest transaction made, Encompass More Asset Management holds 3,349 shares of ABT stock, worth $385,101. This represents 0.15% of its overall portfolio holdings.

Number of Shares
3,349
Previous 3,002 11.56%
Holding current value
$385,101
Previous $312 Million 22.4%
% of portfolio
0.15%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $34,724 - $40,991
347 Added 11.56%
3,349 $382 Million
Q2 2024

Jul 26, 2024

BUY
$100.73 - $112.44 $9,670 - $10,794
96 Added 3.3%
3,002 $312 Million
Q1 2024

May 10, 2024

BUY
$109.52 - $120.96 $318,265 - $351,509
2,906 New
2,906 $330 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Encompass More Asset Management Portfolio

Follow Encompass More Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Encompass More Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Encompass More Asset Management with notifications on news.